How OxyContin taught doctors to trust pills over patients
Treating pain is a notoriously tricky business. But it’s even harder if the medications on which we rely are inappropriately marketed. Last month, a Los Angeles Times investigation of Purdue Pharma asserted that for years, the company falsely elevated the efficacy of its twice-daily OxyContin, a powerful opioid pain reliever. The Times’ review of evidence — including three decades of court cases, investigations, patient and sales rep …
How OxyContin taught doctors to trust pills over patients


![Clinicians are failing at value-based care because no one taught them the system [PODCAST]](https://kevinmd.com/wp-content/uploads/bd31ce43-6fb7-4665-a30e-ee0a6b592f4c-190x100.jpeg)









![Gradually, then suddenly: Dr. Robert Wachter on health care’s giant AI leap [PODCAST]](https://kevinmd.com/wp-content/uploads/unnamed-29-190x100.png)




